Consilient Health signs long-term distribution agreement for elmiron® with bene-Arzneimittel GmbH

Consilient Health are pleased to announce the signing of a long-term, exclusive distribution agreement with bene-Arzneimittel GmbH, a Munich-based pharmaceutical company, to distribute elmiron® in the UK.

elmiron® allows Consilient Health to expand in to the exciting urology segment and is in line with the company’s strategy of partnering with innovative companies to bring to market medicines that serve a clear unmet clinical need.